AlphaValue

The European stocks leader in independent equity research.

  • AlphaValue is the European stocks leader in independent equity research, covering 458 European securities spanning across all sectors. Relying on a team of 25 analysts, AlphaValue provides financial analysis using a robust homogeneous and transparent methodology, enabling pure and pertinent comparisons based on financial and extra-financial criteria.
  • Visit provider site at http://www.alphavalue.com
Login

Latest Content

H1 performance below expectations; strong start to Q3

J D Wetherspoon plc

  • 24 Mar 23
  • -
In-progress balance sheet repair
  • 24 Mar 23
  • -
Weak 2022 results, but survival instinct remains intact

EN+ Group International Public Joint-Stock Company

  • 24 Mar 23
  • -
Improving profitability and cash generation; outlook unchanged

Bastide Le Confort Medical (BLC:EPA)Bastide Le Confort Medical SA (BLC:PAR)

  • 24 Mar 23
  • -
FY2022: Waste and unregulated activities drove the growth

HERA (HER:BIT)Hera S.p.A. (HER:MIL)

  • 23 Mar 23
  • -
FY22: positive momentum for price-over-cost

HeidelbergCement AG

  • 23 Mar 23
  • -
 

AlphaValue Research and Daily Commentaries

Research Tree offers AlphaValue research, providing ongoing coverage of 1587 shares. We offer 15584 reports from AlphaValue on Research Tree.

  • Research reports provided by AlphaValue

  • Companies covered by AlphaValue

  • Sectors covered by AlphaValue


Related Content

View the latest research on other companies in the sector. 

Change makes L’Oréal better

The group has released a very strong year-end trading performance, especially in Asia Pacific. The better than expected revenue growth (9.6% lfl vs. consensus of 7.4%) in Q4 has led the group to finish the year with 8.0% lfl top-line growth and an improved operating margin of 18.6%. Following an annual lfl revenue growth of 25.5%, Asia Pacific (32.3%) has overtaken Europe in becoming the group’s biggest region in terms of sales contribution.

L'Oreal S.A.

  • 10 Feb 20
  • -